Empowered Funds LLC Has $5.50 Million Holdings in Perrigo Company plc $PRGO

Empowered Funds LLC boosted its position in shares of Perrigo Company plc (NYSE:PRGO) by 41.6% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 511,872 shares of the company’s stock after purchasing an additional 150,438 shares during the period. Empowered Funds LLC’s holdings in Perrigo were worth $5,498,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Amundi boosted its position in shares of Perrigo by 11.7% during the first quarter. Amundi now owns 5,292 shares of the company’s stock worth $148,000 after buying an additional 556 shares during the period. Kestra Investment Management LLC grew its holdings in shares of Perrigo by 57.1% during the second quarter. Kestra Investment Management LLC now owns 1,766 shares of the company’s stock worth $47,000 after buying an additional 642 shares in the last quarter. Geneos Wealth Management Inc. raised its position in Perrigo by 439.1% in the 1st quarter. Geneos Wealth Management Inc. now owns 965 shares of the company’s stock valued at $27,000 after buying an additional 786 shares during the last quarter. EverSource Wealth Advisors LLC raised its position in Perrigo by 116.0% in the 4th quarter. EverSource Wealth Advisors LLC now owns 1,888 shares of the company’s stock valued at $26,000 after buying an additional 1,014 shares during the last quarter. Finally, Covestor Ltd lifted its stake in Perrigo by 14.4% in the 4th quarter. Covestor Ltd now owns 8,991 shares of the company’s stock valued at $125,000 after acquiring an additional 1,129 shares in the last quarter. Institutional investors and hedge funds own 95.91% of the company’s stock.

Analysts Set New Price Targets

PRGO has been the subject of a number of recent research reports. Weiss Ratings raised Perrigo from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, July 21st. Zacks Research upgraded shares of Perrigo from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. One equities research analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Perrigo has an average rating of “Hold” and a consensus target price of $19.33.

Perrigo Trading Down 2.2%

Perrigo stock opened at $10.09 on Friday. Perrigo Company plc has a 52 week low of $9.23 and a 52 week high of $27.33. The company has a debt-to-equity ratio of 1.45, a quick ratio of 1.59 and a current ratio of 2.72. The stock has a market capitalization of $1.40 billion, a P/E ratio of -0.77, a PEG ratio of 1.20 and a beta of 0.51. The stock has a 50-day simple moving average of $10.53 and a 200 day simple moving average of $11.64.

Perrigo (NYSE:PRGO) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.43 earnings per share for the quarter, topping analysts’ consensus estimates of $0.39 by $0.04. The firm had revenue of $841.80 million for the quarter, compared to the consensus estimate of $1.04 billion. Perrigo had a positive return on equity of 9.96% and a negative net margin of 43.50%.The business’s revenue was down 7.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.60 earnings per share. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. Analysts expect that Perrigo Company plc will post 2.09 earnings per share for the current year.

Perrigo Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Friday, August 28th will be issued a dividend of $0.29 per share. The ex-dividend date of this dividend is Friday, August 28th. This represents a $1.16 dividend on an annualized basis and a dividend yield of 11.5%. Perrigo’s payout ratio is presently -8.85%.

About Perrigo

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.